Arama
Gelişmiş Arama
Detaylı Arama
Alıcılar
Funding Agencies
Durum
Yayınlanma Tarihi
İlan tipi
Dil
Oturum aç
İlanlarınızı dgMarket.com.tr sitesinde yayınlamak ister misiniz?
tıklayınız...

  12 Bulundu 2023 , Antineplastik ve immünomodulasyon ajanları , Güncel
Buna göre sırala:
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Abatacept (Atc Code: L04Aa24).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
10 Kasım, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Certolizumab Pegol (Atc Code: L04Ab05).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
22 Eylül, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Tocilizumab (Atc Code: L04Ac07).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
22 Eylül, 2023
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fingolimod (Atc Code: L04Aa27).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
14 Ağustos, 2023
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Golimumab (Atc Code: L04Ab06).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
21 Temmuz, 2023
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Nilotinib (Atc Code: L01Ea03).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
11 Temmuz, 2023
Framework Agreement For The Public Procurement Of Medicines Divided Into 135 Lots

Ülke:  Romanya

Tip: Tedarik Planı

$
Yayın Tarihi
13 Haziran, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Infliximab (Atc Code: L04Ab02).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
9 Haziran, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Rituximab (Atc Code: L01Fa01).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
9 Haziran, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Octreotide, In A Dosage Form With Delayed Release Behavior Atc Code: H01Cb02

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
15 Mayıs, 2023
Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products With The Active Ingredient Fulvestrant (Atc Code: L02Ba03).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
7 Nisan, 2023
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With § 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Dasatinib (Atc Code: L01Ea02).

Ülke:  Almanya

Tip: Teklif Çağrısı

$
Yayın Tarihi
31 Ocak, 2023